Kwasi Adu‐Berchie

836 total citations
19 papers, 572 citations indexed

About

Kwasi Adu‐Berchie is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Kwasi Adu‐Berchie has authored 19 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Kwasi Adu‐Berchie's work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (4 papers). Kwasi Adu‐Berchie is often cited by papers focused on CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (4 papers). Kwasi Adu‐Berchie collaborates with scholars based in United States, Israel and Germany. Kwasi Adu‐Berchie's co-authors include David Mooney, Yutong Liu, David Zhang, Joshua M. Brockman, Alexander Stafford, Kyle H. Vining, Nikolaos Dimitrakakis, Benjamin R. Freedman, Kai W. Wucherpfennig and Saemi Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Kwasi Adu‐Berchie

19 papers receiving 566 citations

Peers

Kwasi Adu‐Berchie
Yoonjeong Choi South Korea
Catherine Bessell United States
Chia Chi M. Ho United States
Kyle Dyson United States
Timothy J. Thauland United States
Alexander J. Najibi United States
Byong H. Kang United States
Adam Drake United States
Lu Qiao China
Yoonjeong Choi South Korea
Kwasi Adu‐Berchie
Citations per year, relative to Kwasi Adu‐Berchie Kwasi Adu‐Berchie (= 1×) peers Yoonjeong Choi

Countries citing papers authored by Kwasi Adu‐Berchie

Since Specialization
Citations

This map shows the geographic impact of Kwasi Adu‐Berchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwasi Adu‐Berchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwasi Adu‐Berchie more than expected).

Fields of papers citing papers by Kwasi Adu‐Berchie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwasi Adu‐Berchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwasi Adu‐Berchie. The network helps show where Kwasi Adu‐Berchie may publish in the future.

Co-authorship network of co-authors of Kwasi Adu‐Berchie

This figure shows the co-authorship network connecting the top 25 collaborators of Kwasi Adu‐Berchie. A scholar is included among the top collaborators of Kwasi Adu‐Berchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwasi Adu‐Berchie. Kwasi Adu‐Berchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hodi, F. Stephen, Anita Giobbie‐Hurder, Kwasi Adu‐Berchie, et al.. (2025). First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell–Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma. Cancer Immunology Research. 13(7). 978–989. 5 indexed citations
2.
Lou, Junzhe, Einat B. Vitner, Kwasi Adu‐Berchie, et al.. (2024). Surface‐Functionalized Microgels as Artificial Antigen‐Presenting Cells to Regulate Expansion of T Cells. Advanced Materials. 36(31). e2309860–e2309860. 11 indexed citations
3.
Zhang, David, Joshua M. Brockman, Kwasi Adu‐Berchie, et al.. (2024). Subcutaneous biodegradable scaffolds for restimulating the antitumour activity of pre-administered CAR-T cells. Nature Biomedical Engineering. 9(2). 268–278. 12 indexed citations
4.
Kumbhojkar, Ninad, Supriya Prakash, Tatsuya Fukuta, et al.. (2024). Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy. Nature Biomedical Engineering. 8(5). 579–592. 38 indexed citations
5.
Adu‐Berchie, Kwasi, Joshua M. Brockman, Yutong Liu, et al.. (2023). Adoptive T cell transfer and host antigen-presenting cell recruitment with cryogel scaffolds promotes long-term protection against solid tumors. Nature Communications. 14(1). 3546–3546. 32 indexed citations
6.
Adu‐Berchie, Kwasi, Yutong Liu, David Zhang, et al.. (2023). Generation of functionally distinct T-cell populations by altering the viscoelasticity of their extracellular matrix. Nature Biomedical Engineering. 7(11). 1374–1391. 63 indexed citations
7.
Zhang, David, Kwasi Adu‐Berchie, Yutong Liu, et al.. (2023). Enhancing CAR-T cell functionality in a patient-specific manner. Nature Communications. 14(1). 506–506. 47 indexed citations
8.
Adu‐Berchie, Kwasi, et al.. (2023). T Cell Development and Function. Rejuvenation Research. 26(4). 126–138. 9 indexed citations
9.
Vining, Kyle H., Anna E. Marneth, Kwasi Adu‐Berchie, et al.. (2022). Mechanical checkpoint regulates monocyte differentiation in fibrotic niches. Nature Materials. 21(8). 939–950. 55 indexed citations
10.
Najibi, Alexander J., Ting‐Yu Shih, David Zhang, et al.. (2022). Targeting tumor extracellular matrix activates the tumor-draining lymph nodes. Cancer Immunology Immunotherapy. 71(12). 2957–2968. 13 indexed citations
11.
Berger, Gilles, Erik H. Knelson, Michal O. Nowicki, et al.. (2022). STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models. Proceedings of the National Academy of Sciences. 119(28). e2111003119–e2111003119. 109 indexed citations
12.
Liu, Yutong, Kwasi Adu‐Berchie, Joshua M. Brockman, et al.. (2022). Cytokine conjugation to enhance T cell therapy. Proceedings of the National Academy of Sciences. 120(1). e2213222120–e2213222120. 43 indexed citations
13.
Habibi, Nahal, Tyler Brown, Kwasi Adu‐Berchie, et al.. (2022). Nanoparticle Properties Influence Transendothelial Migration of Monocytes. Langmuir. 38(18). 5603–5616. 9 indexed citations
14.
Freedman, Benjamin R., Kwasi Adu‐Berchie, Carrie E. Barnum, et al.. (2021). Nonsurgical treatment reduces tendon inflammation and elevates tendon markers in early healing. Journal of Orthopaedic Research®. 40(10). 2308–2319. 7 indexed citations
15.
Vining, Kyle H., Anna E. Marneth, Kwasi Adu‐Berchie, et al.. (2021). Mechanical Checkpoint Regulates Monocyte Differentiation in Fibrotic Matrix. Blood. 138(Supplement 1). 2539–2539. 2 indexed citations
16.
Adu‐Berchie, Kwasi & David Mooney. (2020). Biomaterials as Local Niches for Immunomodulation. Accounts of Chemical Research. 53(9). 1749–1760. 101 indexed citations
17.
Adu‐Berchie, Kwasi, et al.. (2019). Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs. Methods in molecular biology. 1974. 41–56. 1 indexed citations
18.
Adu‐Berchie, Kwasi, et al.. (2016). Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing. PubMed. 4(1). 42–54. 11 indexed citations
19.
Carlson, Rebecca J., et al.. (2016). Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference. Nucleic Acid Therapeutics. 26(5). 309–317. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026